Home › NDC Lookup › RxCUI directory › RxCUI 859063

Diclofenac potassium 50 MG Powder for Oral Solution — RxCUI 859063

RxNorm drug concept · Semantic clinical drug
RxCUI 859063 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI859063
Official nameDiclofenac potassium 50 MG Powder for Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asDiclofenac K+ 50 MG Powder for Oral Solution; Diclofenac Pot 50 MG Powder for Oral Solution
FDA products mapped9
Package NDCs mapped13
Reported Medicaid activity (SDUD)1,081 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diclofenac Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • They calm inflammation after cataract surgery. They also temporarily ease pain and light sensitivity after corneal refractive surgery, such as PRK or radial keratotomy.
  • After cataract surgery, it is usually about 4 times a day, starting the day after surgery for the first 2 weeks. For refractive surgery, you use drops before and right after the pr...
  • Brief burning or stinging is the most common complaint, affecting about 15% of people. It usually passes quickly. Tell your doctor if it persists or you notice blurred vision, redn...
  • Be careful and tell your doctor first. People sensitive to aspirin or other NSAIDs may also react to diclofenac. You should not use the drops if you are allergic to any ingredient...
📖 Read our full Diclofenac Ophthalmic guide →

🕸️ Concept Web — How Diclofenac potassium 50 MG Powder for Oral Solut... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Diclofenac potassium 50 MG Powder for Oral Solution RxCUI 859063

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Diclofenac 3355
    • Diclofenac potassium 81997
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cambia 858655
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diclofenac Powder for Oral Solution 1856554
    • Diclofenac potassium Powder for Oral Solution 2649068
    • Diclofenac Oral Powder Product 1856553
    • Diclofenac Oral Product 1151152
    • Diclofenac potassium Oral Powder Product 2662288
    • Diclofenac potassium Oral Product 2670604
    • Diclofenac Powder for Oral Solution [Cambia] 1856557
    • Diclofenac potassium Powder for Oral Solution [Cambia] 2654753
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diclofenac potassium 50 MG SCDC · 855941
  • Diclofenac Powder for Oral Solution SCDF · 1856554
  • Diclofenac potassium Powder for Oral Solution SCDFP · 2649068
  • Diclofenac Oral Powder Product SCDG · 1856553
  • Diclofenac Oral Product SCDG · 1151152
  • Diclofenac potassium Oral Powder Product SCDGP · 2662288
  • Diclofenac potassium Oral Product SCDGP · 2670604

Brand-Name Concepts

  • Diclofenac potassium 50 MG Powder for Oral Solution [Cambia] SBD · 859066
  • Diclofenac potassium 50 MG [Cambia] SBDC · 1856556
  • Diclofenac Powder for Oral Solution [Cambia] SBDF · 1856557
  • Diclofenac potassium Powder for Oral Solution [Cambia] SBDFP · 2654753
  • Cambia Oral Powder Product SBDG · 1856558
  • Cambia Oral Product SBDG · 1172293
  • Cambia BN · 858655

📦 FDA Products & Package NDCs

9 products · 13 package NDCs
13 package NDCs map to RxCUI 859063 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
13668-0672-64 9 PACKET in 1 CARTON (13668-672-64) / 1 POWDER, FOR SOLUTIO... DICLOFENAC POTASSIUM Torrent Pharmaceuticals Limited 2025-01-22
13913-0012-02 9 PACKET in 1 CARTON (13913-012-02) / 1 POWDER, FOR SOLUTIO... Cambia Assertio Therapeutics, Inc. 2016-03-10
13913-0012-03 9 PACKET in 1 CARTON (13913-012-03) / 1 POWDER, FOR SOLUTIO... Cambia Assertio Therapeutics, Inc. 2016-03-10
31722-0046-31 1 POWDER, FOR SOLUTION in 1 PACKET (31722-046-31) Diclofenac potassium Camber Pharmaceuticals, Inc. 2022-03-04
31722-0046-32 9 POWDER, FOR SOLUTION in 1 CARTON (31722-046-32) Diclofenac potassium Camber Pharmaceuticals, Inc. 2022-03-04
49884-0905-64 9 POWDER, FOR SOLUTION in 1 CARTON (49884-905-64) Diclofenac Potassium Endo USA, Inc. 2023-01-03
51672-4240-06 9 PACKET in 1 CARTON (51672-4240-6) / 1 POWDER, FOR SOLUTIO... Diclofenac Potassium Taro Pharmaceuticals U.S.A., Inc. 2024-06-24
60290-0061-01 1 POWDER, FOR SOLUTION in 1 PACKET (60290-061-01) DICLOFENAC POTASSIUM Umedica Laboratories USA Inc. 2026-02-15
60290-0061-02 9 POWDER, FOR SOLUTION in 1 CARTON (60290-061-02) DICLOFENAC POTASSIUM Umedica Laboratories USA Inc. 2026-02-15
67877-0772-58 9 PACKET in 1 CARTON (67877-772-58) / 1 POWDER, FOR SOLUTIO... Diclofenac Potassium Ascend Laboratories, LLC 2022-10-24
69315-0506-09 9 PACKET in 1 CARTON (69315-506-09) / 1 POWDER, FOR SOLUTIO... DICLOFENAC POTASSIUM Leading Pharma, LLC 2022-12-20
75834-0338-01 1 POWDER, FOR SOLUTION in 1 PACKET (75834-338-01) DICLOFENAC POTASSIUM Nivagen Pharmaceuticals, Inc. 2025-12-15
75834-0338-02 9 POWDER, FOR SOLUTION in 1 CARTON (75834-338-02) DICLOFENAC POTASSIUM Nivagen Pharmaceuticals, Inc. 2025-12-15
Observed labelers: Assertio Therapeutics, Inc. (2) · Camber Pharmaceuticals, Inc. (2) · Nivagen Pharmaceuticals, Inc. (2) · Umedica Laboratories USA Inc. (2) · Ascend Laboratories, LLC (1) · Endo USA, Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$12.1109
Range $12.1109–$12.1109 · middle 50% $12.1109–$12.1109 · 7 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.